Short-term prognosis of recipients with pretransplant exposure to immune checkpoint inhibitors after liver transplantation for hepatocellular carcinoma:A retrospective cohort study
Li Pang Wenrui Wu Kwan Man Chao Liu Leibo Xu Zhijun Chen Yang Liu Tao Ding Yanfang Ye Xinjun Lu Guangxiang Gu Haoming Lin
Short-term prognosis of recipients with pretransplant exposure to immune checkpoint inhibitors after liver transplantation for hepatocellular carcinoma:A retrospective cohort study
Short-term prognosis of recipients with pretransplant exposure to immune checkpoint inhibitors after liver transplantation for hepatocellular carcinoma:A retrospective cohort study
摘要
关键词
Immune checkpoint inhibitors(ICIs)/Hepatocellular carcinoma(HCC)/Liver transplantation(LT)/Immunotherapy/Graft rejection/Post-transplant mortality/CD4-CD8 ratioKey words
Immune checkpoint inhibitors(ICIs)/Hepatocellular carcinoma(HCC)/Liver transplantation(LT)/Immunotherapy/Graft rejection/Post-transplant mortality/CD4-CD8 ratio引用本文复制引用
Li Pang,Wenrui Wu,Kwan Man,Chao Liu,Leibo Xu,Zhijun Chen,Yang Liu,Tao Ding,Yanfang Ye,Xinjun Lu,Guangxiang Gu,Haoming Lin..Short-term prognosis of recipients with pretransplant exposure to immune checkpoint inhibitors after liver transplantation for hepatocellular carcinoma:A retrospective cohort study[J].肝脏研究(英文),2025,9(3):221-230,10.基金项目
This study was supported by the National Natural Science Foundation of China(No.82472903,82203747,82173229,and 82173195) (No.82472903,82203747,82173229,and 82173195)
Guangzhou Key Laboratory of Precise Diagnosis and Treatment of Biliary Tract Cancer(No.202201020375) (No.202201020375)
China Postdoctoral Science Foundation(No.2022TQ0388 and 2023M734036) (No.2022TQ0388 and 2023M734036)
Science and Technology Program of Guangzhou(No.202102010326 and 2023A03J0700) (No.202102010326 and 2023A03J0700)
Sun Yat-sen University Clinical Research 5010 Program(No.2018008) (No.2018008)
Sun Yat-sen Me-morial Hospital Clinical Research 5010 Program(No.SYS-5010-202305) (No.SYS-5010-202305)
Sun Yat-sen Pilot Scientific Research Fund(SYSQH-Ⅱ-2024-05). (SYSQH-Ⅱ-2024-05)